We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Fluorescence Analyzers Evaluated for Diagnoses of UTIs

By LabMedica International staff writers
Posted on 10 Sep 2018
Urinary tract infections (UTIs) are among the most frequent infections in both hospitalized and outpatients. More...
As a result, urine specimens constitute a significant proportion of routine microbiology laboratory workload.

Traditional culture remains the “gold standard” for the diagnostic evaluation of patients suspected of having a UTI as it allows the identification of the etiological agents, to estimate the concentration of isolated microorganisms and to offer susceptibility testing for targeting the optimal antibiotic therapy.

Medical microbiologists at the Pordenone Hub Hospital (Pordenone, Italy) evaluated 2,719 midstream urine samples from 1,198 (44.1%) male and 1,521 (55.9%) female, aged from 0 and 97 years (median age = 66 years), submitted to the microbiology laboratory with a specific request for urine culture. Inpatients were 23.9% and outpatients 76.1%. The study was conducted from April 6 to June 12, 2017.

All specimens that passed an exclusion criterion were analyzed with the Sysmex UF-5000 (Sysmex Corporation, Kobe, Japan). The analyzer can discriminate and count 17 diagnostic parameters of cells and formed elements in urine and offers an integrated body fluid mode (BF), available on the instrument with a switch, which can classify and count seven diagnostic parameters. The system employs fluorescence flow cytometry technology, using a new blue semi-conductor laser at 488 nm wavelength, Gram staining of centrifuged specimens was conducted in case of discrepancies between the results of the UF-5000 Bact Info flag and the culture method.

The scientists reported that of the 2,719 samples, 1,922 (70.7%) were negative in urine culture (sterile or ≤ 104 CFU/mL) and 797 (29.3%) showed significant growth. In 574 of the positive samples a single microorganism was identified, in 71 samples two microorganisms were isolated, and 152 samples showed mixed flora. The microorganisms isolated reflected the usual rate of uropathogens in their laboratory, so that the most frequent bacteria reported were Gram negatives accounting for 76.9% of all species isolated, and the majority were Enterobacteriaceae. The UF-5000 showed a very good performance in the screening process. Carryover and cross-contamination was negligible and 797 samples were culture positive at a cut-off of ≥105CFU/mL.

The authors concluded that the new Sysmex UF-5000 showed high diagnostic accuracy in UTI-screening with a very low rate of false negatives. The instrument is capable of predicting Gram negatives with a good standard error and a high agreement with the culture, even if this performance needs further evaluation. The study was published in the September 2018 issue of the journal Clinica Chimica Acta.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Electrolyte Analyzer
BKE-B
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study design and workflow (Parankusham H, Vanderlip C, Birkenbihl C, et al. A two-stage plasma biomarker algorithm reduces amyloid PET use and the p-Tau217 gray zone. Annals of Clinical and Translational Neurology. Published online October 19, 2026. doi:10.1002/acn3.70560)

Two-Step Blood Testing Approach Reduces Uncertainty in Amyloid Assessment

Blood-based biomarkers offer a more accessible, less expensive way to detect Alzheimer’s-related brain changes than traditional methods such as amyloid-beta positron emission tomography (Aβ-PET).... Read more

Molecular Diagnostics

view channel
Image: Tumor DNA is extracted from a pathology sample, and normal DNA is extracted from the buffy coat. Both samples undergo WGS to generate the patient-specific mutational signature. At each follow-up, ctDNA extracted from plasma undergoes WGS and is analyzed using a patient-derived signature and an artificial intelligence (AI) pattern recognition algorithm. FFPE: formalin fixed, paraffin embedded. (Snuderl M, Smadbeck J, Wilkins R, et al. The Journal of Molecular Diagnostics, 2026. DOI: 10.1016/j.jmoldx.2026.07.003)

Liquid Biopsy Detects Lung Cancer Recurrence Signals Months Before Imaging

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and remains a major cause of cancer-related death. Early-stage tumors are often treated surgically, but recurrence can still occur... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image: HETA Quality Control identifies slide quality issues before analysis, while HETA Tumor Detect annotates tumor regions and flags slides likely to contain tumor during scanning. (Photo courtesy of Aignostics)

AI Pathology Platform Targets Workflow Delays and Molecular Test Failures

Pathology laboratories often rely on visual review of tissue slides to assess quality, identify tumors, count mitoses, and estimate tumor content. These tasks can be time-consuming and vary between readers,... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.